BioLife Solutions, Inc. (BLFS)
38.61
0.00 (0.00%)
USD |
NASDAQ |
Oct 09, 16:00
BioLife Solutions Gross Profit Margin (Quarterly) : 63.69% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 63.69% |
| March 31, 2026 | 63.31% |
| December 31, 2025 | 73.59% |
| September 30, 2025 | 61.36% |
| June 30, 2025 | 64.72% |
| March 31, 2025 | 66.81% |
| December 31, 2024 | 65.55% |
| September 30, 2024 | 62.21% |
| June 30, 2024 | 63.53% |
| March 31, 2024 | 62.68% |
| December 31, 2023 | 52.10% |
| September 30, 2023 | 45.32% |
| June 30, 2023 | 32.90% |
| March 31, 2023 | 33.37% |
| December 31, 2022 | 28.28% |
| September 30, 2022 | 27.55% |
| June 30, 2022 | 28.31% |
| March 31, 2022 | 24.60% |
| December 31, 2021 | 8.85% |
| September 30, 2021 | 18.97% |
| June 30, 2021 | 34.51% |
| March 31, 2021 | 49.65% |
| December 31, 2020 | 47.81% |
| September 30, 2020 | 50.95% |
| June 30, 2020 | 47.53% |
| Date | Value |
|---|---|
| March 31, 2020 | 56.78% |
| December 31, 2019 | 49.99% |
| September 30, 2019 | 62.83% |
| June 30, 2019 | 69.08% |
| March 31, 2019 | 71.46% |
| December 31, 2018 | 68.66% |
| September 30, 2018 | 69.65% |
| June 30, 2018 | 70.32% |
| March 31, 2018 | 64.25% |
| December 31, 2017 | 58.71% |
| September 30, 2017 | 63.03% |
| June 30, 2017 | 62.59% |
| March 31, 2017 | 60.76% |
| December 31, 2016 | 60.71% |
| September 30, 2016 | 56.87% |
| June 30, 2016 | 56.14% |
| March 31, 2016 | 58.37% |
| December 31, 2015 | 62.63% |
| September 30, 2015 | 59.65% |
| June 30, 2015 | 54.69% |
| March 31, 2015 | 58.81% |
| December 31, 2014 | 59.76% |
| September 30, 2014 | 47.32% |
| June 30, 2014 | 45.00% |
| March 31, 2014 | 43.75% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Repligen Corp. | 49.25% |
| Agilent Technologies, Inc. | 55.48% |
| Danaher Corp. | 57.64% |
| Thermo Fisher Scientific, Inc. | 40.94% |
| West Pharmaceutical Services, Inc. | 37.83% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 13.52% |
| Return on Assets | 12.39% |
| Return on Invested Capital | 12.88% |
| Operating Margin (Quarterly) | 5.96% |
| Return on Net Operating Assets | 18.17% |